OmniAb, Inc. (OABI)
4.89
-0.02
(-0.41%)
USD |
NASDAQ |
Nov 16, 16:00
4.90
+0.01
(+0.20%)
After-Hours: 20:00
OmniAb Enterprise Value : 667.16M for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 667.16M |
| November 13, 2026 | 670.08M |
| November 12, 2026 | 675.91M |
| November 11, 2026 | 697.79M |
| November 10, 2026 | 697.79M |
| November 09, 2026 | 726.96M |
| November 06, 2026 | 687.58M |
| November 05, 2026 | 658.41M |
| November 04, 2026 | 709.46M |
| November 03, 2026 | 705.08M |
| November 02, 2026 | 696.33M |
| October 30, 2026 | 699.25M |
| October 29, 2026 | 716.75M |
| October 28, 2026 | 724.05M |
| October 27, 2026 | 677.37M |
| October 26, 2026 | 626.32M |
| October 23, 2026 | 633.62M |
| October 22, 2026 | 651.12M |
| October 21, 2026 | 670.81M |
| October 20, 2026 | 677.37M |
| October 19, 2026 | 637.99M |
| October 16, 2026 | 623.41M |
| October 15, 2026 | 643.83M |
| October 14, 2026 | 617.57M |
| October 13, 2026 | 639.45M |
| Date | Value |
|---|---|
| October 12, 2026 | 649.66M |
| October 09, 2026 | 652.58M |
| October 08, 2026 | 633.62M |
| October 07, 2026 | 619.03M |
| October 06, 2026 | 588.40M |
| October 05, 2026 | 671.54M |
| October 02, 2026 | 664.25M |
| October 01, 2026 | 681.75M |
| September 30, 2026 | 677.37M |
| September 29, 2026 | 656.07M |
| September 28, 2026 | 656.07M |
| September 25, 2026 | 637.17M |
| September 24, 2026 | 663.34M |
| September 23, 2026 | 663.34M |
| September 22, 2026 | 682.24M |
| September 21, 2026 | 632.81M |
| September 18, 2026 | 616.81M |
| September 17, 2026 | 612.45M |
| September 16, 2026 | 599.37M |
| September 15, 2026 | 599.37M |
| September 14, 2026 | 618.27M |
| September 11, 2026 | 558.66M |
| September 10, 2026 | 541.21M |
| September 09, 2026 | 550.66M |
| September 08, 2026 | 583.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 57.65B |
| Champions Oncology, Inc. | 72.32M |
| Medpace Holdings, Inc. | 17.55B |
| Charles River Laboratories International, Inc. | 18.74B |
| Avantor, Inc. | 13.60B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.73M |
| Revenue (Quarterly) | 3.993M |
| Total Expenses (Quarterly) | 19.72M |
| EPS Diluted (Quarterly) | -0.1216 |
| Gross Profit Margin (Quarterly) | -13.10% |
| Profit Margin (Quarterly) | -393.9% |
| Earnings Yield | -6.92% |
| Normalized Earnings Yield | -7.027 |